We serve Chemical Name:vanadocene CAS:1277-47-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:vanadocene
CAS.NO:1277-47-0
Synonyms:BIS(CYCLOPENTADIENYL)VANADIUM;cyclopenta-1,3-diene,vanadium(2+);MFCD00058735
Molecular Formula:C10H10V
Molecular Weight:181.12800
HS Code:
Physical and Chemical Properties:
Melting point:165-167ºC
Boiling point:200ºC 0,1mm
Density:N/A
Index of Refraction:
PSA:
Exact Mass:181.02200
LogP:2.04300
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2926 4
Packing Group:III
Contact us for information like BIS(CYCLOPENTADIENYL)VANADIUM chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00058735 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,BIS(CYCLOPENTADIENYL)VANADIUM Use and application,BIS(CYCLOPENTADIENYL)VANADIUM technical grade,usp/ep/jp grade.
Related News: Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. vanadocene manufacturer Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. vanadocene supplier But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. vanadocene vendor Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. vanadocene factory Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.
